MCID: ATM019
MIFTS: 42

Autoimmune Polyendocrine Syndrome malady

Categories: Genetic diseases, Endocrine diseases, Immune diseases, Rare diseases, Reproductive diseases, Blood diseases

Aliases & Classifications for Autoimmune Polyendocrine Syndrome

About this section

Aliases & Descriptions for Autoimmune Polyendocrine Syndrome:

Name: Autoimmune Polyendocrine Syndrome 10 12
Polyendocrinopathies, Autoimmune 36 65
Autoimmune Polyglandular Failure 10
 
Polyendocrinopathies Autoimmune 47
Autoimmune Polyendocrinopathy 10
Lloyd's Syndrome 10

Classifications:



External Ids:

Disease Ontology10 DOID:14040
ICD1027 E31.0
MeSH36 D016884
NCIt42 C84576
UMLS65 C0085409

Summaries for Autoimmune Polyendocrine Syndrome

About this section
Disease Ontology:10 An autoimmune disease of endocrine system characterized by abnormal functioning of the immune system that causes auto-reactivity against endocrine organs.

MalaCards based summary: Autoimmune Polyendocrine Syndrome, also known as polyendocrinopathies, autoimmune, is related to autoimmune polyendocrine syndrome type 2 and autoimmune polyendocrine syndrome type 1. An important gene associated with Autoimmune Polyendocrine Syndrome is AIRE (Autoimmune Regulator), and among its related pathways are Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics and Amine-derived hormones. Affiliated tissues include endothelial, brain and t cells, and related mouse phenotypes are no phenotypic analysis and endocrine/exocrine gland.

Wikipedia:68 In medicine, autoimmune polyendocrine syndromes, also called polyglandular autoimmune syndrome (PGAS),... more...

Related Diseases for Autoimmune Polyendocrine Syndrome

About this section

Diseases in the Autoimmune Polyendocrine Syndrome family:

Autoimmune Polyendocrine Syndrome Type 1 Autoimmune Polyendocrine Syndrome Type 2

Diseases related to Autoimmune Polyendocrine Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 121)
idRelated DiseaseScoreTop Affiliating Genes
1autoimmune polyendocrine syndrome type 232.1AIRE, CASR, CYP11A1, CYP21A2, DDC, IL17A
2autoimmune polyendocrine syndrome type 112.7
3autoimmune polyendocrinopathy syndrome , type i, with or without reversible metaphyseal dysplasia11.9
4autoimmune polyglandular syndrome type 311.6
5autoimmune polyendocrinopathy type 411.6
6autoimmune polyendocrinopathy type 311.6
7autoimmune polyglandular syndrome type 211.5
8autoimmune polyendocrinopathy type 211.5
9autosomal dominant congenital stationary night blindness10.4AIRE, CYP21A2
10atrichia with papular lesions10.4AIRE, CYP21A2
11children's interstitial lung disease10.3GAD1, TPH1
12lung cancer10.3
13obesity10.3
14leukemia10.3
15spinal cord injury10.3
16lymphoma10.3
17encephalitis10.3
18primary hyperparathyroidism10.3AIRE, CASR
19spondylocostal dysostosis-anal and genitourinary malformations syndrome10.2CYP11A1, CYP21A2
20breast hemangioma10.2CYP11A1, CYP21A2
21richter's syndrome10.2CYP11A1, CYP21A2
22renal adenoma10.2CYP11A1, CYP21A2
23bipolar ll disorder10.2GAD2, TPH1
24neuroblastoma 410.2GAD1, GAD2
25gastrointestinal stromal tumor10.2
26colorectal cancer10.2
27porphyria cutanea tarda10.2
28chediak-higashi syndrome10.2
29hepatocellular carcinoma10.2
30achondroplasia10.2
31anorexia nervosa10.2
32keratitis10.2
33retinoblastoma10.2
34androgen insensitivity10.2
35hemochromatosis10.2
36pulmonary hypertension10.2
37atherosclerosis10.2
38bronchopulmonary dysplasia10.2
39hepatitis10.2
40hydrocephalus10.2
41liver cirrhosis10.2
42polycystic ovary syndrome10.2
43thrombocytopenia10.2
44familial hemiplegic migraine10.2
45diaphragmatic eventration10.2
46epidural abscess10.2
47heart disease10.2
48pyelonephritis10.2
49xanthogranulomatous pyelonephritis10.2
50hepatorenal syndrome10.2

Graphical network of the top 20 diseases related to Autoimmune Polyendocrine Syndrome:



Diseases related to autoimmune polyendocrine syndrome

Symptoms for Autoimmune Polyendocrine Syndrome

About this section

Drugs & Therapeutics for Autoimmune Polyendocrine Syndrome

About this section

Drugs for Autoimmune Polyendocrine Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cyclophosphamideapproved, investigationalPhase 2264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
2
Miconazoleapproved, investigationalPhase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
3
Amphotericin Bapproved, investigationalPhase 21171397-89-314956, 5280965
Synonyms:
12633-72-6
1397-89-3
30782-62-8
5-18-10-00525 (Beilstein Handbook Reference)
54482-28-9
8055-20-7
AB00513832
ABLC
AC1L1CN2
AC1L24V6
AC1L70KF
AC1L73U6
AC1NQXTD
AC1NTQ32
AC1NUQG4
AC1NY9JC
AC1O7GCZ
AC1O8FQV
AC1O8PFK
AI3-26528
AMPH-B
AMPH-b
Abelcet
Abelecet
AmBisome (TN)
Ambap1397-89-3
Ambisome
Amfotericina B
Amfotericina B [INN-Spanish]
Ampho-Moronal
Amphocin
Amphomoronal
Amphortericin B
Amphotec
Amphotec (TN)
Amphotericin
Amphotericin .BETA.
Amphotericin B
Amphotericin B (JP15/USP/INN)
Amphotericin B Cholesterol Dispersion
Amphotericin B Cholesteryl Sulfate Complex
Amphotericin B Colloidal Dispersion
Amphotericin B [USAN:INN:JAN]
Amphotericin B, Lipid-based
Amphotericin B, Streptomyces sp.
Amphotericin-B
Amphotericine B
Amphotericine B [INN-French]
Amphotericinum
Amphotericinum B
Amphotericinum B [INN-Latin]
Amphotherizin
Amphotherizin [German]
Amphotéricine B
Amphozone
BIDD:GT0351
BPBio1_000374
BRN 0078342
BSPBio_000340
C-AmB
C06573
C47H73NO17
CCRIS 5963
CHEBI:2682
CHEMBL1200646
CHEMBL267345
CID10533925
CID10629638
CID10677275
CID14956
 
CID1972
CID352546
CID354192
CID5280965
CID5386092
CID5458486
CID5771695
CID6604295
CID6708817
CID6713692
CID9919339
D00203
DB00681
DivK1c_007045
EINECS 215-742-2
Fungilin
Fungisome
Fungisone
Fungizone
Fungizone (TN)
HMS1569A22
HSDB 3008
HSDB 3008 IAB
Halizon
I06-0257
KBio1_001989
KBio2_000551
KBio2_003119
KBio2_005687
KBioGR_002298
KBioSS_000551
LMPK06000002
LNS-AmB
LS-187721
LS-93
Liposomal Amphotericin B
Liposomal amphotericin b
MLS002702966
MolPort-006-392-260
Mysteclin-F
NCGC00014913
NCGC00090808-01
NCGC00098014-01
NCGC00179595-01
NCI527017
NCI60_004288
NCIStruc1_001042
NCIStruc2_000920
NKTR-024
NS 718
NSC 527017
NSC-527017
NSC527017
Prestwick0_000410
Prestwick1_000410
Prestwick2_000410
Prestwick3_000410
Prestwick_721
SMP1_000302
SMR001566780
SPBio_000715
SPBio_002279
ST50999656
SinuNase
SpecPlus_000949
Spectrum2_000818
Spectrum4_001779
Spectrum_000111
UNII-7XU7A7DROE
amophotericin B
amphotericin B liposomal
amphotericin b
4Antineoplastic Agents, AlkylatingPhase 23406
5Antirheumatic AgentsPhase 28496
6lenograstimPhase 21134
7Alkylating AgentsPhase 23582
8Immunosuppressive AgentsPhase 210422
9Immunologic FactorsPhase 218483
10AutoantibodiesPhase 2117
11Liposomal amphotericin BPhase 2117
12Antiprotozoal AgentsPhase 21730
13Antifungal AgentsPhase 23015
14Anti-Bacterial AgentsPhase 29140
15Anti-Infective AgentsPhase 217220
16Antiparasitic AgentsPhase 21854

Interventional clinical trials:

idNameStatusNCT IDPhase
1Cyclophosphamide in Treating Young Patients With Severe Autoimmune EnteropathyCompletedNCT00258180Phase 2
2CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisRecruitingNCT02629419Phase 2
3Studies of Disorders With Increased Susceptibility to Fungal InfectionsRecruitingNCT01222741
4Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down SyndromeNot yet recruitingNCT02421276

Search NIH Clinical Center for Autoimmune Polyendocrine Syndrome


Cochrane evidence based reviews: polyendocrinopathies, autoimmune

Genetic Tests for Autoimmune Polyendocrine Syndrome

About this section

Anatomical Context for Autoimmune Polyendocrine Syndrome

About this section

MalaCards organs/tissues related to Autoimmune Polyendocrine Syndrome:

33
Endothelial, Brain, T cells, Colon, Breast, Myeloid, Testes

Animal Models for Autoimmune Polyendocrine Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Autoimmune Polyendocrine Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030128.5AIRE, FOXP3, GAD1, GAD2, IL17A
2MP:00053798.3AIRE, CASR, CYP11A1, FOXP3, GAD1, GAD2
3MP:00053888.1AIRE, FOXP3, GAD1, GAD2, IL17A, TPH1
4MP:00053818.1AIRE, CASR, FOXP3, GAD1, GAD2, IL17A
5MP:00053877.7AIRE, CASR, CYP11A1, DDC, FOXP3, GAD2
6MP:00053867.4AIRE, CASR, CYP11A1, DDC, FOXP3, GAD1
7MP:00107686.9AIRE, CASR, CYP11A1, DDC, FOXP3, GAD1
8MP:00053766.7AIRE, CASR, CYP11A1, DDC, FOXP3, GAD1
9MP:00053786.4AIRE, CASR, CYP11A1, DDC, FOXP3, GAD1

Publications for Autoimmune Polyendocrine Syndrome

About this section

Articles related to Autoimmune Polyendocrine Syndrome:

(show top 50)    (show all 88)
idTitleAuthorsYear
1
Behavioral Treatment of Pseudobulbar Affect: A Case Report. (27091117)
2016
2
A rare long-term survival of the life-threatening trio: silent myocardial infarction complicated by ventricular septal rupture, type 2 diabetes mellitus and chronic bronchitis. (26543616)
2015
3
A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature. (26502871)
2015
4
Progress towards poliomyelitis eradication in Nigeria, January 2014- July 2015. (26298883)
2015
5
Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis*. (24196192)
2014
6
Association between a single nucleotide polymorphism in the TP53 region and risk of ovarian cancer. (25060098)
2014
7
Debate on obesity medicine. (24386663)
2013
8
New focus of active transmission of Chagas disease in indigenous populations in the Peruvian Amazon basin. (23856870)
2013
9
Marked inhibition of Na+, K(+)- ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease. (23151916)
2013
10
Study of risk factors for gastric cancer by populational databases analysis. (24409066)
2013
11
Mycobacterial infection of the gallbladder masquerading as gallbladder cancer with a false positive pet scan. (23573099)
2013
12
Laboratory diagnosis of antiphospholipid syndrome. (23820326)
2013
13
Fibrillary glomerulonephritis: a diagnosis not to be missed'. (23168858)
2012
14
Use of triple-convergence polypropylene thread for the aesthetic correction of partial facial paralysis caused by the facial nerve injury. (23174786)
2012
15
Expression of BRMS1 gene protein in nasal and paranasal sinus carcinomas]. (22239051)
2011
16
Genetic susceptibility for individual cooperation preferences: the role of monoamine oxidase A gene (MAOA) in the voluntary provision of public goods. (21698196)
2011
17
HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population. (20352225)
2011
18
Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. (21465511)
2011
19
Insights into pathophysiology of punding reveal possible treatment strategies. (20489735)
2010
20
LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. (20421648)
2010
21
Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. (20082598)
2010
22
PACAP/PAC1R signaling modulates acetylcholine release at neuronal nicotinic synapses. (19958833)
2010
23
Molecular basis of catecholaminergic polymorphic ventricular tachycardia. (19121813)
2009
24
Churg-Strauss Syndrome in childhood: a clinical review. (19893067)
2009
25
Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges. (18847306)
2008
26
A study of rectal mucosa administration of IL-2 in treatment of HIV/AIDS: a novel method for the treatment of HIV/AIDS. (18832891)
2008
27
Association of KIR2DS4 and its variant KIR1D with leukemia. (18463675)
2008
28
Pleiotropic Roles of PDX-1 in the Pancreas. (18338074)
2007
29
Transcription of the human cell cycle regulated BUB1B gene requires hStaf/ZNF143. (17478512)
2007
30
Relationship between the expression of vascular endothelial growth factor, fms-like tyrosine kinase-1 and biological behavior in gastric carcinoma]. (17633783)
2007
31
Cervicomedullary decompression for foramen magnum stenosis in achondroplasia. (16572633)
2006
32
Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: comparison with that on tyrosine hydroxylase activity. (16581181)
2006
33
Nelarabine: a new purine analog in the treatment of hematologic malignancies. (18473971)
2006
34
Role of IL-6 and its -174G>C polymorphism in weight management and in the metabolic comorbidities associated with obesity]. (16421614)
2005
35
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis. (15725351)
2005
36
Osteomalacia due to chemotherapy-induced Fanconi syndrome in an adult patient. (15975640)
2005
37
Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. (15158329)
2004
38
Role of Plk2 (Snk) in mouse development and cell proliferation. (12972611)
2003
39
Surfactant proteins as genetic determinants of multifactorial pulmonary diseases. (12452477)
2002
40
The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. (11490306)
2001
41
Physical characterization of the procollagen module of human thrombospondin 1 expressed in insect cells. (11016937)
2000
42
Laparoscopic removal of an autoamputated ovarian cyst in an infant. (9563048)
1998
43
Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. (9052888)
1997
44
Serum interleukin-1 beta in neonatal sepsis. (8695999)
1996
45
Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. (8566049)
1996
46
Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. (7822660)
1995
47
Serodiagnosis of western equine encephalitis virus infections: relationships of antibody titer and test to observed onset of clinical illness. (6618970)
1983
48
Echocardiographic classification of hypertensive heart disease. A correlative study with clinical features. (125353)
1975
49
Tuberculous Laryngitis. (21312437)
1926
50

Variations for Autoimmune Polyendocrine Syndrome

About this section

Expression for genes affiliated with Autoimmune Polyendocrine Syndrome

About this section
Search GEO for disease gene expression data for Autoimmune Polyendocrine Syndrome.

Pathways for genes affiliated with Autoimmune Polyendocrine Syndrome

About this section

Pathways related to Autoimmune Polyendocrine Syndrome according to GeneCards Suite gene sharing:

(show all 11)
idSuper pathwaysScoreTop Affiliating Genes
19.8DDC, TPH1
2
Show member pathways
9.8DDC, TPH1
3
Show member pathways
9.8DDC, TPH1
4
Show member pathways
9.4DDC, TPH1
5
Show member pathways
9.4GAD1, GAD2
69.4GAD1, GAD2
7
Show member pathways
9.4GAD1, GAD2
89.4GAD1, GAD2
9
Show member pathways
8.7DDC, GAD1, GAD2, TPH1
108.6CYP21A2, GAD1, GAD2
11
Show member pathways
8.5FOXP3, GAD1, GAD2, IL17A

GO Terms for genes affiliated with Autoimmune Polyendocrine Syndrome

About this section

Cellular components related to Autoimmune Polyendocrine Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1clathrin-sculpted gamma-aminobutyric acid transport vesicle membraneGO:00612029.4GAD1, GAD2

Biological processes related to Autoimmune Polyendocrine Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1indolalkylamine biosynthetic processGO:00462199.8DDC, TPH1
2serotonin biosynthetic processGO:00424279.5DDC, TPH1
3sterol metabolic processGO:00161259.0CYP11A1, CYP21A2

Sources for Autoimmune Polyendocrine Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet